| 國立成功大學 |
2023 |
Switching to coformulated bictegravir, emtricitabine, and tenofovir alafenamide maintained viral suppression in adults with historical virological failures and K65N/R mutation
|
Tsai, M.-S.;Sun, H.-Y.;Chen, Chen C.-P.;Lee, C.-H.;Lee, C.-Y.;Liu, C.-E.;Tang, H.-J.;Hung, T.-C.;Li, C.-W.;Lee, Y.-T.;Liou, B.-H.;Yang, C.-J.;Hung, C.-C. |
| 國立成功大學 |
2023 |
Optimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter Study
|
Sun, H.-Y.;Liou, B.-H.;Chen, T.-C.;Yang, C.-J.;Huang, S.-H.;Lu, P.-L.;Huang, C.-H.;Tsai, M.-S.;Cheng, S.-H.;Lee, N.-Y.;Ko, W.-C.;Chen, Y.-H.;Liu, W.-D.;Lin, S.-Y.;Lin, S.-P.;Chen, P.-L.;Syue, L.-S.;Huang, Y.-S.;Chuang, Y.-C.;Chen, Chen C.-B.;Chang, Y.-T.;Lee, Y.-T.;Hsieh, S.-M.;Su, L.-H.;Cheng, Cheng C.-Y.;Hung, C.-C. |
| 臺大學術典藏 |
2022-09-16T08:49:04Z |
Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide
|
Liou B.-H.; Cheng C.-N.; Lin Y.-T.; Lin Y.-J.; Chuang Y.-C.; Lin K.-Y.; Liu W.-C.; Lin S.-W.; CHING-HUA KUO; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:19Z |
Hepatitis C microelimination among people living with HIV in Taiwan
|
Chen G.-J.; Ho S.-Y.; Su L.-H.; Chang S.-Y.; Hsieh S.-M.; Sheng W.-H.; WANG-DA LIU; Huang Y.-S.; Lin K.-Y.; Chen Y.-T.; Su Y.-C.; Liu W.-C.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:18Z |
Effectiveness of COVID-19 vaccination among people living with HIV during a COVID-19 outbreak
|
Lin K.-Y.; Wu P.-Y.; WANG-DA LIU; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Huang Y.-S.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:17Z |
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
|
Chen G.-J.; Sun H.-Y.; Chen L.-Y.; Hsieh S.-M.; Sheng W.-H.; WANG-DA LIU; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Wu P.-Y.; Chang H.-Y.; Luo Y.-Z.; Su Y.-C.; Liu W.-C.; Chang S.-F.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:17Z |
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations
|
Sun H.-Y.; WANG-DA LIU; Wang C.-W.; Wei Y.-J.; Lin K.-Y.; Huang Y.-S.; Su L.-H.; Chen Y.-T.; Liu W.-C.; Su Y.-C.; Chen Y.-W.; Chuang Y.-C.; Lu P.-L.; Hung C.-C.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-15T05:42:30Z |
Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
|
Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Su L.-H.; Chen Y.-T.; Hsieh S.-M.; Liu W.-D.; Sheng W.-H.; Huang Y.-S.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:29Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu P.-Y.; Sun H.-Y.; Chen M.-Y.; Sheng W.-H.; Hsieh S.-M.; Chuang Y.-C.; Chang H.-Y.; Luo Y.-Z.; Zhang J.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:29Z |
Hepatitis C microelimination among people living with HIV in Taiwan
|
Chen G.-J.; Ho S.-Y.; Su L.-H.; Chang S.-Y.; Hsieh S.-M.; Sheng W.-H.; Liu W.-D.; Huang Y.-S.; Lin K.-Y.; Chen Y.-T.; Su Y.-C.; Liu W.-C.; Sun H.-Y.; CHIEN-CHING HUNG |
